Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphoma.

Oncology reports

Volumn 10, Issue 6, 2003, Pages 1915-1917

  Bieker, Ralf ^a   Kessler, Torsten ^a   Berdel, Wolfgang E ^a   Mesters, Rolf M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; PLATINUM; RITUXIMAB;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; HUMAN; LYMPHOSARCOMA; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, DIFFUSE; MIDDLE AGED; PLATINUM; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 2642584278     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.10.6.1915     Document Type: Article

References (0)